Clinical-grade Recombinant Proteins for Cell Therapy
May 04 2022
The demand for cell therapy grade proteins
Continued expansion of cell therapy applications across healthcare and the life sciences is driving a rapidly increasing need for clinically applicable ancillary materials. A key requirement is for recombinant proteins, such as growth factors and cytokines. This demand for clinically applicable recombinant proteins places stringent requirements on product quality, lot-to-lot consistency, and compliance with all relevant laws and regulations.
StemFit Purotein® from AMSBIO are a range of high purity, high activity recombinant proteins for cell therapy applications.
Animal-origin free, high purity GMP-grade recombinant proteins
All StemFit Purotein® products are designed and manufactured under a strict animal-free protocol which minimises risk of virus contamination and ensures high lot-to-lot consistency. Manufactured using a streamlined (optionally GMP compliant) production and purification process results in recombinant proteins of the highest purity and quality while maintaining affordable prices. The StemFit Purotein® range includes recombinant proteins that play key roles in differentiation of ES and iPS cells into liver, pancreas, kidney, heart, blood, and immune cells. Beneficially, StemFit Purotein® products are supplied in a ‘ready-to-use’ frozen liquid form which eliminates the time-consuming process of reconstitution while ensuring consistent results.
Purotein® products are fully compatible with the StemFit® range of xeno-free, chemically defined media which is proven to effectively maintain induced pluripotent stem cells (iPSCs) and embryonic stem cells (ESCs) under feeder-free conditions during the reprogramming, expansion and differentiation phases of stem cell culture and growth medium.
More information online
In This Edition Evaluation of Recovery of Basic Analytes Using a Mixed-Mode Strong Cation Exchange SPE Microplate by HPLC-MS The Benefits of SEC-MALLS in Biopharmaceutical Applications...
View all digital editions
Jul 24 2022 Chicago, IL, USA
Jul 24 2022 Virtual event
Aug 21 2022 Chicago, IL, USA & Online
Aug 22 2022 Frankfurt, Germany
Aug 27 2022 Maastricht, Netherlands